R&D
Là où votre curiosité fait avancer les miracles de la science

The R&D Patient Engagement Country Leads are responsible for ensuring integrated patient engagement is implemented in key countries to drive the differentiation, acceleration, awareness and access of our clinical trials. Working closely with the Health Value Translation Leads, they support the creation of the Patient Disease Strategy (PDS) by facilitating local integration of patient insights & perspectives with a focus on forward translation of insights (eg, to GPTs, study teams) and back translation (eg, global insights integrated at local levels) into tangible local strategies that ultimately lead to increasing the value of the pipeline from the perspective of local stakeholders. This position extends beyond the classical patient insights generation and clinical trial operations activities by having direct accountability for aligning the PDS at the local level.

This position is also responsible for making sure local stakeholders are aligned with the PDS and well anticipated by relevant local stakeholders, notably the engagement strategy with forward looking implications related to Policy, Regulatory Policy, Clin Ops, Payer value. Verticalization of local patient pathways and other patient relevant business insights, to feed the PDS, Clinical Development Plan (CDP), Integrated Patient Journey (IPJ) and clinical trial designs is core to ensuring the local country perspectives are embedded early and effectively.

 Major Duties/Responsibilities:

• Responsible for the development, and oversight, of local patient advocacy R&D collaborations at the local levels and ensuring these are connected to global strategy, across the multi-therapeutic portfolio starting at the earliest phases of R&D (dependent upon the asset for when the indication is identified)

• • These collaborations are expected to achieve the following, at min:

  • • Alignment with local and/ or global public affairs as it relates to the strategic intent, and plans, for each local PAG

    • Be strategic in nature with transparency across local (and global, as relevant) stakeholders to maximize the engagements. For instance, patient meetings include PA and MA to address their objectives in a given indication

    • Mutual benefit between Sanofi and the PAG at the indication level with positive customer experience reflected in surveys such as the Partnership Quality Survey (PQS)

    • Deliver on local differentiation, acceleration, awareness and access goals for each program/ indication/ clinical trial and be reflected in the PDS

    • Acceleration of the clinical trial and / or program can be evidenced because of the collaboration (eg, PED utilized to optimize study design, PED integrated into reg strategy for accelerated review, patient recruitment timelines impacted, etc). The objectives and expected outcomes of each collaboration are to be documented at the start of the engagement efforts and in the PDS

    • Fully leverage digital and data opportunities that exist within patient advocacy groups

• Responsible, in collaboration with peers in other countries, for achieving the annually defined PQS survey results that reflect % of PAG partners rating Sanofi R&D activities as Excellent

• As it relates to acceleration of clincial trials, this position is responsible for establishing, aligning and integrating strategic opportunities with their CSU colleagues. These acceleration opportunities are expected to have measurable impact

• Accountable to work with peers in other countries and the HVT leads to perform a patient data/ PDS gap analysis and address knowledge needs for each indication.

• Expertly leverage digital opportunities to achieve efficiencies in job function and accelerate deliverables

• Accountable for ensuring the TVP/TPP/ iEGP reflect local patient priorities

• Translation of local insights to ensure patient preference is clearly identified in endpoint and outcomes measurement selection

• Act as the main point of contact to the HVT and COA teams to define meaningful patient insights from the respective country, to increase the value of the asset as reflected in the PDS (TVP/TPP/TPL/iEGP)

• Responsible for creating the local IPJ for each indication

• Responsible for the identication, and integration, of local RWE data opportunities into the PDS

• Accountable for identifying clinical trial innovation with a strong focus on patient centric digital strategies and working cross functionally for integration/ adoption, as relevant.

The R&D Patient Engagement Country Lead is also expected to:

• Assume leadership opportunities to evolve the role and overall, IPE objectives of Sanofi at the local and global levels

• Participate in cross-functional external patient centric initiatives (PFDD, IMI, TransCelerate, PALADIN, etc) shaping the broader R&D patient centricity ecosystem

• Leverage external trends/policy positions and integrate into development

• Work closely with Public and Corporate Affairs, Ethics & Business Integrity to stay abreast of regional regulations and changes

• Collaborate with cross functionally to develop, and deliver, internal and external webinars and publications related to Sanofi’s R&D IPE achievements  

• Assist with the project management of innovation concepts being piloted

null

Poursuivre le progrès. Découvrir l’Extraordinaire.

Rejoignez Sanofi et entrez dans une nouvelle ère de la science – où votre parcours peut être aussi transformateur que le travail que nous accomplissons. Nous investissons en vous pour que vous alliez plus loin, accélériez votre réflexion et accomplissiez ce qui n’a jamais été fait auparavant. Vous contribuerez à repousser les limites, à bousculer les conventions et à concevoir des solutions plus intelligentes pour les communautés que nous servons. Prêt·e à poursuivre les miracles de la science et à améliorer la vie des gens ? Poursuivons le progrès et découvrons l’extraordinaire – ensemble.

Chez Sanofi, nous croyons dans l’égalité des chances, sans distinction de race, de couleur, d’ascendance, de religion, de sexe, d’origine, d’orientation sexuelle, d’âge, de citoyenneté, d’état civil, de handicap, d’identité de genre ou de tout autre critère protégé par la loi.